399 related articles for article (PubMed ID: 18437602)
21. The promise of thalidomide: evolving indications.
Joglekar S; Levin M
Drugs Today (Barc); 2004 Mar; 40(3):197-204. PubMed ID: 15148528
[TBL] [Abstract][Full Text] [Related]
22. The thalidomide saga.
Melchert M; List A
Int J Biochem Cell Biol; 2007; 39(7-8):1489-99. PubMed ID: 17369076
[TBL] [Abstract][Full Text] [Related]
23. [The return of thalidomide].
Rossi G
Recenti Prog Med; 2001 Mar; 92(3):213-6. PubMed ID: 11320855
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity.
Breitkreutz I; Anderson KC
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):973-85. PubMed ID: 18624684
[TBL] [Abstract][Full Text] [Related]
25. Thalidomide: from tragedy to promise.
von Moos R; Stolz R; Cerny T; Gillessen S
Swiss Med Wkly; 2003 Feb; 133(5-6):77-87. PubMed ID: 12644961
[TBL] [Abstract][Full Text] [Related]
26. Influence of morphine on host immunity.
Chang MC; Fan SZ; Hsiao PN; Cheng WF; Sun WZ
Acta Anaesthesiol Taiwan; 2011 Sep; 49(3):105-8. PubMed ID: 21982172
[TBL] [Abstract][Full Text] [Related]
27. [Refractory anaemia successfully treated with thalidomide].
Hansen M; Hansen PB
Ugeskr Laeger; 2006 Feb; 168(6):591-2. PubMed ID: 16476224
[TBL] [Abstract][Full Text] [Related]
28. Kellersberger Memorial Lecture 1979: immunosuppressive/anti-inflammatory thalidomide analogues.
Hastings RC
Ethiop Med J; 1980 Apr; 18(2):65-71. PubMed ID: 7418703
[No Abstract] [Full Text] [Related]
29. Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro.
Sampaio EP; Hernandez MO; Carvalho DS; Sarno EN
Biomed Pharmacother; 2002 Feb; 56(1):13-9. PubMed ID: 11905505
[TBL] [Abstract][Full Text] [Related]
30. Thalidomide in advanced mastocytosis.
Damaj G; Bernit E; Ghez D; Claisse JF; Schleinitz N; Harlé JR; Canioni D; Hermine O
Br J Haematol; 2008 Apr; 141(2):249-53. PubMed ID: 18307561
[TBL] [Abstract][Full Text] [Related]
31. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
32. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
[TBL] [Abstract][Full Text] [Related]
33. [Thalidomide: the revival].
Grosbois B; Duguet C
Rev Med Interne; 2001 Jan; 22(1):5-7. PubMed ID: 11218298
[No Abstract] [Full Text] [Related]
34. [Thalidomide: a review of the literature].
dos Santos Júnior MF; Lombardi C; Belda W
Hansenol Int; 1981 Dec; 6(2):136-45. PubMed ID: 7349301
[No Abstract] [Full Text] [Related]
35. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide. A new beginning.
Valorie AM
Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
[No Abstract] [Full Text] [Related]
37. Potential novel uses of thalidomide: focus on palliative care.
Peuckmann V; Fisch M; Bruera E
Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide, a drug which may protect the organism against some aggressive effects of the immunologic system.
Mathé G
Biomed Pharmacother; 2002 Feb; 56(1):1-3. PubMed ID: 11905504
[No Abstract] [Full Text] [Related]
39. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
Vetrichevvel TP; Pise GA; Thappa DM
Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
[TBL] [Abstract][Full Text] [Related]
40. Thalidomide: an old drug with new action.
Kumar V; Chhibber S
J Chemother; 2011 Dec; 23(6):326-34. PubMed ID: 22233815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
